Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InMed Pharmaceuticals (INM) Other Operating Expenses: 2022-2025

Historic Other Operating Expenses for InMed Pharmaceuticals (INM) over the last 4 years, with Jun 2025 value amounting to $191,106.

  • InMed Pharmaceuticals' Other Operating Expenses rose 408.21% to $110,196 in Q3 2025 from the same period last year, while for Sep 2025 it was $279,619, marking a year-over-year increase of 579.68%. This contributed to the annual value of $191,106 for FY2025, which is 166.99% up from last year.
  • Per InMed Pharmaceuticals' latest filing, its Other Operating Expenses stood at $191,106 for FY2025, which was up 166.99% from $71,579 recorded in FY2024.
  • InMed Pharmaceuticals' 5-year Other Operating Expenses high stood at $191,106 for FY2025, and its period low was -$19.3 million during FY2022.
  • Over the past 3 years, InMed Pharmaceuticals' median Other Operating Expenses value was $71,579 (recorded in 2024), while the average stood at -$6.3 million.
  • Data for InMed Pharmaceuticals' Other Operating Expenses shows a peak YoY surged of 166.99% (in 2025) over the last 5 years.
  • InMed Pharmaceuticals' Other Operating Expenses (Yearly) stood at -$19.3 million in 2022, then remained steady at -$19.3 million in 2023, then surged by 100.37% to $71,579 in 2024, then surged by 166.99% to $191,106 in 2025.